Image

HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Investigational Treatment for Pancreatic Cancer

Recruiting
18-80 years
All
Phase 2

This study investigates the treatment of pancreatic cancer using an investigational medication alongside gemcitabine and albumin-bound paclitaxel. The purpose of this study is to explore new therapeutic options for this condition.

The study evaluates the safety and effectiveness of this combination treatment. It looks at how patients respond to the treatment and any side effects they may experience.

  • Who can participate: Adults aged 18 to 80 with confirmed pancreatic cancer and at least one measurable lesion can participate. Participants must have a performance status of 0 or 1.
  • Study details: Participants will receive an investigational medication with other treatments.
Study details
    Pancreatic Cancer

NCT06587061

Ruijin Hospital

31 July 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.